Miguel

Nexteam talent
Miguel — surname withheld
Investment Banking
Miguel — surname withheld
Investment Banking
Miguel is a Corporate Development Associate, evaluating acquisitions, building valuation models, coordinating due diligence, and preparing Investment Committee and Board recommendations. He remains hands-on with DCFs, projections, sensitivities, transaction structures, and investment-risk analysis. His completed transactions exceed USD 1 billion in aggregate value, including the acquisition of a listed software company.
Earlier, he led sell-side investment banking work across healthcare, fintech, technology, and education. His healthcare experience includes provider operating models, patient-volume scenarios, payer risk, capacity analysis, and earn-out structuring. Miguel combines buy-side and sell-side execution with clear, decision-focused financial analysis.
Education & Certifications
Postgraduate Program in Corporate Finance
Business school
2020
Bachelor's Degree in Finance and Foreign Affairs
University
2014
Availability on request
Colombia
Full name and employer details shared on request.
Skills & Expertise
Industry Expertise
Corporate Development Associate
Evaluating acquisition opportunities and preparing financial analyses to support capital allocation decisions. Building and reviewing DCF models, financial projections, valuation proposals, scenario analyses, sensitivity analyses, and accretion-dilution models.
Senior Investment Analyst
Evaluated energy, water, and waste infrastructure investments across Colombia and Panama. Built project finance models and economic evaluations using NPV, IRR, and debt service coverage analysis.
Investment Banking Director
Closed multiple transactions exceeding USD 150 million across fintech, technology, and education. Led valuation, financial modelling, and projection workstreams for sell-side processes.
Investment Banking Analyst
Executed the sell-side transaction of a specialized healthcare provider. Supported the sale of a majority stake to a private equity investor.
Investment Banking Junior Analyst
Supported target identification, financial modelling, and M&A execution. Worked across pharmaceutical, healthcare, food and beverage, and logistics transactions.
Fintech and payments company
Corporate Development Associate
Started 2023
- Evaluating acquisition opportunities and preparing financial analyses to support capital allocation decisions;
- Building and reviewing DCF models, financial projections, valuation proposals, scenario analyses, sensitivity analyses, and accretion-dilution models;
- Designing capex allocation approaches for technology-intensive fintech targets and assessing their impact on profitability and cash generation;
- Identifying key investment risks, challenging assumptions, and preparing recommendations for senior management and the Board of Directors;
- Coordinating due diligence and acting as the link between vendors, internal teams, senior leadership, and external advisors;
- Working with investment banks, strategy consultants and professional services firms across transaction workstreams;
- Supporting M&A coverage across multiple Latin American and Caribbean markets;
- Closing transactions exceeding USD 1 billion in aggregate value across fintech, payments, AI, and cloud-based platforms;
- Coordinating due diligence for the acquisition of a publicly listed software company;
- Supporting financing structures and post-acquisition value creation tracking;
- Delegating routine data collection and formatting while retaining ownership of assumptions, valuations, and final investment recommendations.
Infrastructure and environmental services company
Senior Investment Analyst
2021–2023
- Evaluated energy, water, and waste infrastructure investments across Colombia and Panama;
- Built project finance models and economic evaluations using NPV, IRR, and debt service coverage analysis;
- Structured a water treatment project for the oil and gas sector;
- Structured a gas-fueled trigeneration plant for a beverage company;
- Supported the renegotiation of the beverage-company contract following engine failures and unplanned capital expenditure;
- Analyzed the impact of a tariff indexation formula that did not capture increases in Colombian natural gas prices;
- Evaluated a solar self-generation project for a water treatment plant;
- Incorporated macroeconomic, country-risk, regulatory, and market variables into investment recommendations for regional teams and global headquarters.
Investment banking advisory firm
Investment Banking Director
2019–2021
- Closed multiple transactions exceeding USD 150 million across fintech, technology, and education;
- Led valuation, financial modelling, and projection workstreams for sell-side processes;
- Managed sell-side transaction execution from initial analysis through investor engagement and closing;
- Prepared investor presentations and supported management meetings;
- Advised founders, family offices, and strategic investors on valuation, financial structuring, and liquidity considerations.
Investment banking advisory firm
Investment Banking Analyst
2017–2019
- Executed the sell-side transaction of a specialized healthcare provider;
- Supported the sale of a majority stake to a private equity investor;
- Structured the remaining interest through an EBITDA-linked earn-out, contingent on EBITDA growth;
- Built the healthcare provider's operating model and DCF from scratch using historical cost centers, regional patient-population drivers, installed capacity, and expansion capex;
- Tested patient-volume assumptions using historical trends, regional demand, capacity constraints, and downside scenarios;
- Evaluated the impact of patient growth on revenue, EBITDA, cash flow, and valuation;
- Supported a 7x to 9x EBITDA valuation against the shareholders' initial expectation of approximately 10x EBITDA;
- Supported the sale of a maternity clinic to an investment firm;
- Valued a specialist care operator and an intermediate-care provider using population-driven demand models;
- Supported creditor claim capitalization and reorganization plans for healthcare insurers in insolvency proceedings;
- Managed M&A processes for healthcare and industrial clients, including a transaction with an investment manager;
- Provided financial analysis, data room oversight, and valuation support for transactions totaling more than USD 60 million.
Corporate finance advisory firm
Investment Banking Junior Analyst
2015–2016
- Supported target identification, financial modelling, and M&A execution;
- Worked across pharmaceutical, healthcare, food and beverage, and logistics transactions;
- Supported the sale of a pharmaceutical company to an international healthcare group.
Interested in learning more about this candidate or scheduling a call?
Let us know, and we’ll follow up shortly.